University of Colorado Cancer Center

Clinical research site in Aurora, Colorado

Part of University of Colorado

As of July 2026, 38 paid clinical trials are recruiting at University of Colorado Cancer Center in Aurora, Colorado. Active studies at this site cover conditions such as Breast Cancer, Advanced Solid Tumor and Melanoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at University of Colorado Cancer Center (38)

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for Ovarian Cancer

38 locations incl. Anchorage

Sponsor: Incyte Corporation

Sex: Female·Age: 18+

Code: NCT07214779·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

for Metastatic Castration-resistant Prostate Neoplasms

53 locations incl. La Jolla

Sponsor: Janssen Research & Development, LLC

Sex: Male·Age: 18+

Code: NCT07164443·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for Melanoma

93 locations incl. Chandler

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06246916·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for Neoplasms

77 locations incl. Birmingham

Sponsor: Celgene

Sex: All·Age: All ages

Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018

Apply to this trial

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for Solid Tumors

43 locations incl. Tucson

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT03486873·Phase 3·Recruiting·Listed Apr 2018

Apply to this trial

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

for Metastatic Colorectal Cancer

19 locations incl. Phoenix

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT04929223·Phase 1·Recruiting·Listed Jun 2021

Apply to this trial

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for Breast Cancer

24 locations incl. Los Angeles

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT05768139·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for HER2 Mutation-Related Tumors

29 locations incl. La Jolla

Sponsor: Iambic Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT06253871·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

for Gastrointestinal Stromal Tumor (GIST)

32 locations incl. Birmingham

Sponsor: Kura Oncology, Inc.

Sex: All·Age: 18+

Code: NCT06655246·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for Breast Cancer

113 locations incl. Anchorage

Sponsor: Agendia

Sex: All·Age: 18+

Code: NCT03053193·Recruiting·Listed Feb 2017

Apply to this trial

A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

for ALK-positive NSCLC

11 locations incl. San Francisco

Sponsor: TRIANA Biomedicines, Inc.

Sex: All·Age: 18+

Code: NCT07491497·Phase 1, Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

for Metastatic Melanoma

18 locations incl. Birmingham

Sponsor: Iovance Biotherapeutics, Inc.

Sex: All·Age: 18 - 70

Code: NCT05727904·Phase 3·Recruiting·Listed Feb 2023

Apply to this trial

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

for Advanced Lung Cancer

16 locations incl. Phoenix

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT06892548·Phase 1, Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

for Gastrointestinal Cancer

8 locations incl. Aurora

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06596694·Phase 1, Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for Locally Advanced Solid Tumor

20 locations incl. Orange

Sponsor: Nuvalent Inc.

Sex: All·Age: 12+

Code: NCT05384626·Phase 1, Phase 2·Recruiting·Listed May 2022

Apply to this trial

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

14 locations incl. Los Angeles

Sponsor: ModernaTX, Inc.

Sex: All·Age: 12+

Code: NCT05533697·Phase 1, Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer

22 locations incl. Birmingham

Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All·Age: 18+

Code: NCT06343402·Phase 1·Recruiting·Listed Apr 2024

Apply to this trial

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

for Non-Small Cell Lung Cancer (NSCLC)

18 locations incl. Orange

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT06128551·Phase 1, Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

for Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen

22 locations incl. Los Angeles

Sponsor: Servier Bio-Innovation LLC

Sex: All·Age: 18+

Code: NCT06127407·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

for Non Small Cell Lung Cancer

24 locations incl. Beverly Hills

Sponsor: SystImmune Inc.

Sex: All·Age: 18+

Code: NCT05983432·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

for Metastatic Breast Cancer

14 locations incl. Gilbert

Sponsor: Olema Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT05508906·Phase 1·Recruiting·Listed Aug 2022

Apply to this trial

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

for Advanced Solid Tumor

13 locations incl. Los Angeles

Sponsor: Volastra Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05902988·Phase 1, Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

CtDNA Based MRD Testing for NAC Monitoring in TNBC

for TNBC - Triple-Negative Breast Cancer

14 locations incl. Tucson

Sponsor: Personalis Inc.

Sex: Female·Age: 18+

Code: NCT06230185·Recruiting·Listed Jan 2024

Apply to this trial

A Study of BG-C477 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

9 locations incl. Goodyear

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06596473·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

5 locations incl. Los Angeles

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06233942·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

for Advanced Cancer

4 locations incl. Aurora

Sponsor: 7 Hills Pharma, LLC

Sex: All·Age: 18+

Code: NCT06362369·Phase 1, Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

BfedBwell INSPIRE Pilot

for Cancer Survivorship

1 location in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 75

Code: NCT07446595·Recruiting·Listed Mar 2026

Apply to this trial

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

for Rectal Adenocarcinoma

3 locations incl. Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 100

Code: NCT07292298·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

for Breast Neoplasms

33 locations incl. Birmingham

Sponsor: QuantumLeap Healthcare Collaborative

Sex: All·Age: 18+

Code: NCT01042379·Phase 2·Recruiting·Listed Jan 2010

Apply to this trial

Relationships Between Physical Activity and Different Measures of Fatigue in Cancer Survivors

for Cancer Remission

1 location in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18+

Code: NCT05073848·Recruiting·Listed Oct 2021

Apply to this trial

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

for Lung Cancer

3 locations incl. Stanford

Sponsor: Joshua Palmer

Sex: All·Age: 18+

Code: NCT05987644·Phase 1, Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

for Renal Cancer

3 locations incl. Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18+

Code: NCT05969496·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

for Uveal Melanoma

3 locations incl. Aurora

Sponsor: Diwakar Davar

Sex: All·Age: 18+

Code: NCT06070012·Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

for Breast Cancer

2 locations in Aurora

Sponsor: University of Colorado, Denver

Sex: Female·Age: 21+

Code: NCT06430541·Phase 1·Recruiting·Listed May 2024

Apply to this trial

Microbiome in Head and Neck Squamous Cell Carcinoma

for Head and Neck Cancer

1 location in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 100

Code: NCT05837221·Recruiting·Listed May 2023

Apply to this trial

Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

for Pancreatic Ductal Adenocarcinoma (PDAC)

1 location in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18+

Code: NCT07030283·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer

for Lung Neoplasms

1 location in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 85

Code: NCT01580982·Recruiting·Listed Apr 2012

Apply to this trial

Specimen Banking From Patients With Lung Cancer

for Lung Neoplasms

1 location in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 85

Code: NCT01585675·Recruiting·Listed Apr 2012

Apply to this trial

More research sites in Aurora

Children's Hospital Colorado (176 trials)
University of Colorado Anschutz Medical Campus (106 trials)
University of Colorado (86 trials)
University of Colorado Hospital (56 trials)
UCHealth University of Colorado Hospital (50 trials)
Rocky Mountain Regional VA Medical Center, Aurora, CO (31 trials)
University of Colorado Denver (29 trials)
University of Colorado Anschutz (21 trials)
Childrens Hospital Colorado (16 trials)
Children's Hospital of Colorado (14 trials)

Explore more

Paid clinical trials in Aurora, CO · Colorado clinical trials